Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,679.99
(
0.62%
)
News Focus
News Focus
Post# of 447748
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

The Irishman

Send PM Follow Ignore
Followers 21
Posts 878
Boards Moderated 0
Alias Born 02/09/2019

The Irishman

Re: postes post# 333792

Wednesday, 04/07/2021 9:08:39 PM

Wednesday, April 07, 2021 9:08:39 PM

Post# of 447748
Quite true. If Vascepa was unique in terms of cardiovascular risk reduction, then it would be a different story. There would be a compelling need. Managed care would cover without question. However, there are other meds that present similar outcomes. Perhaps not as good, yet just enough for some managed care plans to act this way
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News